Longeveron Inc (LGVN) Profitability Comparisons, Net Margin, Gross Margin, Tax rate, Cash Flow Margin Comparisons - CSIMarket
CSIMarket Company Name, Ticker, Suppliers, else..
 


• Gross Margin
• EBITDA Margin
• Operating Margin
• Net Margin
• Pre-Tax Margin
• Effective Tax Rate
• Free Cash Flow Margin
• Cash Flow Margin
Longeveron Inc   (NASDAQ: LGVN)

Longeveron Inc Profitability Comparisons

Select each Category to receive further Information



Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.

LGVN Profitability Ratio

 Company Industry Sector S&P 500
Gross Profit Margin (Q2 MRQ) 63.41 % 70.91 % 65.43 % 46.06 %
Gross Margin (Q2 TTM) 69.76 % 71.73 % 66.39 % 46.3 %
Gross Profit Margin 5 Yr. Avg. 46.32 % 67.82 % 65.56 % 47.82 %
EBITDA Margin (Q2 MRQ) 251.22 % 22.25 % 19.59 % 20.7 %
EBITDA Margin (Q2 TTM) -1338.33 % 25.28 % 20.86 % 19.16 %
EBITDA Margin 5 Yr. Avg. --1018.73 % 47.09 % 31.58 % 22.44 %
Operating Margin (Q2 MRQ) -2150.17 % 17.27 % 16.57 % 16.03 %
Operating Margin (Q2 TTM) -1992.84 % 20.33 % 17.92 % 16.33 %
Operating Margin 5 Yr. Avg. --1682.41 % 15.37 % 14.33 % 17.24 %
Pre-Tax Profit Margin (Q2 MRQ) 0 % 13.66 % 10.93 % 13.94 %
Pre-Tax Profit Margin (Q2 TTM) -1465.96 % 16.7 % 12.86 % 13.09 %
Pre-Tax Profit Margin 5 Yr. Avg. - 12.99 % 10.37 % 12.42 %
Net Margin (Q2 MRQ) -2116.03 % 10.09 % 8.14 % 11.41 %
Net Margin (Q2 TTM) -1977.59 % 13.13 % 9.99 % 10.76 %
Net Margin 5 Yr. Avg. - 5.8 % 6.08 % 9.9 %



Business Segment Profit Margin
 
Clinical trial revenue
  Explore Clinical trial revenue Segment  -
Reportable Segment
  Explore Reportable Segment Segment  -
Reportable Segment Aggregation Before Other Operating Segment
  Explore Reportable Segment Aggregation Before Other Operating Segment Segment  -